Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion

Acta Ophthalmol. 2008 Dec;86(8):925-7. doi: 10.1111/j.1755-3768.2008.01175.x. Epub 2008 May 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Fovea Centralis / blood supply*
  • Humans
  • Injections
  • Ischemia / chemically induced*
  • Macular Edema / drug therapy*
  • Macular Edema / etiology*
  • Male
  • Retinal Vein Occlusion / chemically induced*
  • Vitreous Body

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab